Walgreens shareholders received $11.45 per share in cash when Sycamore Partners completed its acquisition in August 2025, with the potential for up to an additional $3 per share from future proceeds of selling its VillageMD holdings. This means shareholders got a base payment of $11.45 per share, plus a non-transferable right (DAP Right) for potential future payments from VillageMD (Village Medical, Summit Health, CityMD), bringing the total potential value up to $14.45 per share.
Sycamore Partners completes acquisition of Walgreens (WBA) Sycamore Partners completed its acquisition of Walgreens (WBA) on August 28, 2025. Shareholders of WBA received $11.45 in cash for each share held at the close of trading on August 27, 2025.
1. Deal terms and valuation. Walgreens shareholders approved the $10 billion acquisition at a July 11 special meeting. Shareholders received $11.45 per share in cash, totaling about $9.9 billion based on Walgreens' 865 million outstanding shares.
Walgreens is being taken private
The deal is expected to close in the second half of 2025, with Walgreens shareholders getting $11.45 per share in cash. That's all that investors here can expect to receive if they buy Walgreens.
The transaction closed and WBA common stock ceased public trading. Guaranteed cash: Former public WBA holders received $11.45 in cash per share as the primary, immediate merger consideration.
What Shareholders Need to Know
Walgreens (WBA) has been analyzed by 2 analysts, with a consensus rating of Sell. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 50% predict a Strong Sell.
In addition to their cash consideration of $11.45 per WBA share, WBA shareholders will receive one non-transferable right to receive up to an additional $3.00 in cash per WBA share from the net proceeds of the future monetization of WBA's debt and equity interests in VillageMD, which includes the Village Medical, ...
Walgreens is closing about 1,200 underperforming stores over three years, with roughly 500 slated for closure in their fiscal year 2025 (ending August 2025) as part of a cost-cutting "Footprint Optimization Program" due to financial pressures like decreased spending and competition. While a comprehensive list of all locations isn't released, specific closures occurred in cities like San Francisco, Macon, and Brooklyn, with many in May/June 2025, impacting states like California, Illinois, New Jersey, and North Carolina.
Walgreens' dividend streak comes to an end
30, pharmacy retailer Walgreens announced that it was suspending its quarterly dividend. The company is refining its strategy as it looks to improve its financials amid a broader turnaround effort.
In August, Sycamore finalized its acquisition of Walgreens and appointed Mike Motz as the company's new CEO, with Wentworth remaining on the company's board. Sycamore will also split the company into five separate businesses: Walgreens, The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD.
Experts from across the healthcare industry agree that while Walgreens is currently in a grim financial situation, recovery is still possible. To make this happen, the company will have to relinquish its retail clinic dreams and focus more on making its core pharmacy business as efficient as it can.
What Is the Walgreens Boots Alliance Inc Stock Price Today? The Walgreens Boots Alliance Inc stock price today is 11.980. What Is the Stock Symbol for Walgreens Boots Alliance Inc? The stock ticker symbol for Walgreens Boots Alliance Inc is WBA.
Your focus should be on the company's fundamentals and its long-term potential for growth. A stock split doesn't change the intrinsic value of the company; it simply makes shares more affordable. However, for those seeking short-term gains, buying before the split could be advantageous.
Data as of Time Period Studied: 2005-2024. Walgreens' payout ratio before its dividend cut was certainly a red flag. According to data appearing on the Dividends tab of Walgreens Boots Alliance's stock page on Morningstar.com, its payout ratio at the end of 2023 was a shocking 290.91%.
Walgreens stock will cease trading, and shareholders will receive $11.45 per share plus an additional up to $3 per share from the net proceeds of any potential future sales of VillageMD, the company said.
Walgreens: Growth Outlook and Valuation
One of the main drivers of the low stock price is disappointing financial results. In its latest quarterly report (Q2 2024), Walgreens reported a net loss of $1.2 billion, compared to a profit in the same period last year. Revenue growth has stagnated, and same-store sales have underperformed expectations.